Interview: Novartis Counts On AS and PsA For Cosentyx Growth

 
• By Kevin Grogan
  
Husky
Novartis looks to lead the pack in AS and PsA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category